SUMMIT THERAPEUTICS PLC

CUSIP: 86627R102 Class: Stock

LANSDOWNE PARTNERS (UK) LLP's Holding History (CIK: 0001608485)

Note: Option positions (PUT/CALL) are excluded.

Q2 2020
Shares 2,667,350 Value ($000) $7,922 Avg Close — Range —
Q1 2020
Shares 4,228,700 Value ($000) $10,022 Avg Close — Range —
Q4 2019
Shares 1,596,666 Value ($000) $2,555 Avg Close — Range —
Q3 2019
Shares 1,596,666 Value ($000) $2,858 Avg Close — Range —
Q2 2019
Shares 1,596,666 Value ($000) $2,020 Avg Close — Range —
Q1 2019
Shares 1,596,666 Value ($000) $2,922 Avg Close — Range —
Q4 2018
Shares 1,596,666 Value ($000) $1,836 Avg Close — Range —
Q3 2018
Shares 1,596,666 Value ($000) $3,545 Avg Close — Range —
Q2 2018
Shares 1,596,666 Value ($000) $3,912 Avg Close — Range —
Q1 2018
Shares 1,596,666 Value ($000) $20,597 Avg Close — Range —
Q4 2017
Shares 1,596,666 Value ($000) $17,691 Avg Close — Range —
Q3 2017
Shares 1,596,666 Value ($000) $20,038 Avg Close — Range —
Q2 2017
Shares 930,000 Value ($000) $10,593 Avg Close — Range —
Q1 2017
Shares 930,000 Value ($000) $12,346 Avg Close — Range —
Q4 2016
Shares 930,000 Value ($000) $7,961 Avg Close — Range —
Q3 2016
Shares 930,000 Value ($000) $8,430 Avg Close — Range —
Q2 2016
Shares 930,000 Value ($000) $7,524 Avg Close — Range —
Q1 2016
Shares 930,000 Value ($000) $6,343 Avg Close — Range —
Q4 2015
Shares 930,000 Value ($000) $10,695 Avg Close — Range —
Q3 2015
Shares 930,000 Value ($000) $9,681 Avg Close — Range —
Q2 2015
Shares 930,000 Value ($000) $9,823 Avg Close — Range —
Q1 2015
Shares 930,000 Value ($000) $11,523 Avg Close — Range —